The European Vaccines Manufacturers (EVM), a specialised group within the European Federation of Pharmaceutical Industries and Associations (EFPIA), has represented Europe’s vaccines sector since 1991. Today marks a new chapter in the development of the industry with the launch of Vaccines Europe.
“Vaccines Europe represents a highly innovative and diverse global industry with a strong position in Europe which we strive to maintain,” said Andrea Rappagliosi, President of Vaccines Europe. “We are exploring the option of expanding our membership to include small and medium sized enterprises (SMEs) in the future. Along with established players in the vaccine sector which have a track record of innovation, smaller companies are an important source of fresh ideas, new jobs and economic growth in Europe”.
Working on regulatory issues, market access, influenza and public communication, Vaccines Europe aims to continue to be a constructive partner in public health dialogue at European level. Vaccines Europe and its member companies are committed to their continuing contribution to the health of European citizens by developing and providing vaccines for public health needs.